Real-time near-infrared imaging distinguishes nasopharyngeal colonization from aspiration of Streptococcus pneumoniae and identifies aspiration as a trigger of severe disease

Pneumonia is a familiar threat, particularly to older adults, yet the bacteria that cause it often live quietly in the human body without causing harm. A common type of bacteria, known as Streptococcus pneumoniae, frequently settles in the upper part of the throat and nose, called the nasopharynx. In this location, the bacteria can remain harmless for years, simply coexisting with the host. However, the same organism can become deadly if it moves deeper into the body, invading the lungs and triggering a severe infection. For a long time, scientists have understood that this shift from a harmless resident to a lethal invader is dangerous, but the exact moment and mechanism that trigger this change have remained unclear. The central question has been whether the initial location where the bacteria land determines the outcome of the infection. Does the bacteria need to be swallowed into the lungs immediately to cause trouble, or can it start in the nose and move down later? Understanding this distinction is vital because it could change how we think about preventing severe disease, moving beyond just counting bacteria to understanding where they go.

To answer this, researchers developed a new way to watch bacteria move in real time, using a method that does not require altering the bacteria's genetic code. They labeled the bacteria with a special dye called indocyanine green, which glows under near-infrared light, a type of light invisible to the human eye but detectable by sensitive cameras. This dye was added simply by mixing it with the bacteria, a process that left the bacteria healthy and growing normally at body temperature. The team then introduced these glowing bacteria into mice and used a high-speed camera to record the first ten minutes of the infection. This continuous video revealed two very different paths the bacteria could take. In some cases, the bacteria stayed confined to the upper throat, a state the researchers identified as colonization. In other cases, the bacteria were immediately drawn down into the lower respiratory tract, a process known as aspiration. The technology allowed the scientists to see these events as they happened, distinguishing between a bacteria that stayed put and one that was inhaled into the lungs within seconds.

The consequences of these two different paths were stark and immediate. The researchers tracked the mice over several days and found that those whose bacteria were aspirated into the lungs faced a much higher risk of death compared to those where the bacteria remained in the nose. This difference was so pronounced that the risk of dying was nearly eight times higher for the mice that experienced aspiration, a result that held true for both young and older mice. The fact that the older mice were given ten times fewer bacteria than the young ones yet still suffered the same high mortality rate when aspiration occurred suggests that the location of the bacteria is a more critical factor than the sheer number of bacteria present. The deaths in these groups began on the third day, marking a rapid decline once the bacteria entered the lower airways.

To understand why aspiration led to such severe outcomes, the team examined the bodies of the mice twenty-four hours after infection. By analyzing the blood, they found that the mice who had aspirated the bacteria showed a massive activation of the body's defense systems. Their blood contained high levels of signals that trigger inflammation and the production of new immune cells. Furthermore, the blood showed signs of increased activity in the systems that help blood clot and fight off invaders. These findings indicate that the act of aspiration itself sets off a chain reaction in the body, engaging powerful immune pathways that, while intended to protect, appear to contribute to the severity of the disease. The study establishes that the physical movement of bacteria from the nose to the lungs is a key trigger for severe illness, and it introduces a new imaging tool that can watch this critical moment unfold, linking the early behavior of the bacteria directly to the body's systemic response.